RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy

Cutaneous malignant melanoma is one of the most serious skin cancers and is highly invasive and markedly resistant to conventional therapy. Melanomagenesis is initially triggered by environmental agents including ultraviolet (UV), which induces genetic/epigenetic alterations in the chromosomes of me...

Full description

Saved in:
Bibliographic Details
Main Authors: Ichiro Yajima, Mayuko Y. Kumasaka, Nguyen Dinh Thang, Yuji Goto, Kozue Takeda, Osamu Yamanoshita, Machiko Iida, Nobutaka Ohgami, Haruka Tamura, Yoshiyuki Kawamoto, Masashi Kato
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Dermatology Research and Practice
Online Access:http://dx.doi.org/10.1155/2012/354191
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561062229049344
author Ichiro Yajima
Mayuko Y. Kumasaka
Nguyen Dinh Thang
Yuji Goto
Kozue Takeda
Osamu Yamanoshita
Machiko Iida
Nobutaka Ohgami
Haruka Tamura
Yoshiyuki Kawamoto
Masashi Kato
author_facet Ichiro Yajima
Mayuko Y. Kumasaka
Nguyen Dinh Thang
Yuji Goto
Kozue Takeda
Osamu Yamanoshita
Machiko Iida
Nobutaka Ohgami
Haruka Tamura
Yoshiyuki Kawamoto
Masashi Kato
author_sort Ichiro Yajima
collection DOAJ
description Cutaneous malignant melanoma is one of the most serious skin cancers and is highly invasive and markedly resistant to conventional therapy. Melanomagenesis is initially triggered by environmental agents including ultraviolet (UV), which induces genetic/epigenetic alterations in the chromosomes of melanocytes. In human melanomas, the RAS/RAF/MEK/ERK (MAPK) and the PI3K/PTEN/AKT (AKT) signaling pathways are two major signaling pathways and are constitutively activated through genetic alterations. Mutations of RAF, RAS, and PTEN contribute to antiapoptosis, abnormal proliferation, angiogenesis, and invasion for melanoma development and progression. To find better approaches to therapies for patients, understanding these MAPK and AKT signaling mechanisms of melanoma development and progression is important. Here, we review MAPK and AKT signaling networks associated with melanoma development and progression.
format Article
id doaj-art-6ffffbe9ee3649839c49f24e32566010
institution Kabale University
issn 1687-6105
1687-6113
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Dermatology Research and Practice
spelling doaj-art-6ffffbe9ee3649839c49f24e325660102025-02-03T01:26:01ZengWileyDermatology Research and Practice1687-61051687-61132012-01-01201210.1155/2012/354191354191RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and TherapyIchiro Yajima0Mayuko Y. Kumasaka1Nguyen Dinh Thang2Yuji Goto3Kozue Takeda4Osamu Yamanoshita5Machiko Iida6Nobutaka Ohgami7Haruka Tamura8Yoshiyuki Kawamoto9Masashi Kato10Unit of Environmental Health Sciences, Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi 487-8501, JapanUnit of Environmental Health Sciences, Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi 487-8501, JapanUnit of Environmental Health Sciences, Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi 487-8501, JapanUnit of Environmental Health Sciences, Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi 487-8501, JapanUnit of Environmental Health Sciences, Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi 487-8501, JapanUnit of Environmental Health Sciences, Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi 487-8501, JapanUnit of Environmental Health Sciences, Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi 487-8501, JapanUnit of Environmental Health Sciences, Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi 487-8501, JapanUnit of Environmental Health Sciences, Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi 487-8501, JapanUnit of Environmental Health Sciences, Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi 487-8501, JapanUnit of Environmental Health Sciences, Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi 487-8501, JapanCutaneous malignant melanoma is one of the most serious skin cancers and is highly invasive and markedly resistant to conventional therapy. Melanomagenesis is initially triggered by environmental agents including ultraviolet (UV), which induces genetic/epigenetic alterations in the chromosomes of melanocytes. In human melanomas, the RAS/RAF/MEK/ERK (MAPK) and the PI3K/PTEN/AKT (AKT) signaling pathways are two major signaling pathways and are constitutively activated through genetic alterations. Mutations of RAF, RAS, and PTEN contribute to antiapoptosis, abnormal proliferation, angiogenesis, and invasion for melanoma development and progression. To find better approaches to therapies for patients, understanding these MAPK and AKT signaling mechanisms of melanoma development and progression is important. Here, we review MAPK and AKT signaling networks associated with melanoma development and progression.http://dx.doi.org/10.1155/2012/354191
spellingShingle Ichiro Yajima
Mayuko Y. Kumasaka
Nguyen Dinh Thang
Yuji Goto
Kozue Takeda
Osamu Yamanoshita
Machiko Iida
Nobutaka Ohgami
Haruka Tamura
Yoshiyuki Kawamoto
Masashi Kato
RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy
Dermatology Research and Practice
title RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy
title_full RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy
title_fullStr RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy
title_full_unstemmed RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy
title_short RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy
title_sort ras raf mek erk and pi3k pten akt signaling in malignant melanoma progression and therapy
url http://dx.doi.org/10.1155/2012/354191
work_keys_str_mv AT ichiroyajima rasrafmekerkandpi3kptenaktsignalinginmalignantmelanomaprogressionandtherapy
AT mayukoykumasaka rasrafmekerkandpi3kptenaktsignalinginmalignantmelanomaprogressionandtherapy
AT nguyendinhthang rasrafmekerkandpi3kptenaktsignalinginmalignantmelanomaprogressionandtherapy
AT yujigoto rasrafmekerkandpi3kptenaktsignalinginmalignantmelanomaprogressionandtherapy
AT kozuetakeda rasrafmekerkandpi3kptenaktsignalinginmalignantmelanomaprogressionandtherapy
AT osamuyamanoshita rasrafmekerkandpi3kptenaktsignalinginmalignantmelanomaprogressionandtherapy
AT machikoiida rasrafmekerkandpi3kptenaktsignalinginmalignantmelanomaprogressionandtherapy
AT nobutakaohgami rasrafmekerkandpi3kptenaktsignalinginmalignantmelanomaprogressionandtherapy
AT harukatamura rasrafmekerkandpi3kptenaktsignalinginmalignantmelanomaprogressionandtherapy
AT yoshiyukikawamoto rasrafmekerkandpi3kptenaktsignalinginmalignantmelanomaprogressionandtherapy
AT masashikato rasrafmekerkandpi3kptenaktsignalinginmalignantmelanomaprogressionandtherapy